Customer Service 1 (888) 261-2693
Please enter Search keyword. Advanced Search
Home About Us Resources Archive Free Reports Market Window
To search the DailyWealth archives, enter your search terms below…
Search for:
  Please enter Search keyword.
Editor:
From: To:
Match: any search words all search words
Sort: by relevance by date
Search results for:
5 results found
How Arabs Will Drive the Next Great Infrastructure Boom
Most of us know China's boom is a huge driver in the bull market in infrastructure, energy, metals, and minerals. But there's another developing region you've probably never considered... one that could make you a rich investor over the coming years: the Middle East.
DailyWealth | June 5, 2008
Why Australia Could Become the Next Stock Mania
DailyWealth | May 24, 2008
The Last Secret Left in the Mining Industry
The Pilbara region of western Australia looks a lot like stretches of Utah... burnt oranges and reds highlighted by spinifex, a bushy grass unique to Australia. But the special thing about this place from an investor's perspective is this...
DailyWealth | May 15, 2008
The Coming Boom in Australian Resource Stocks
Australia's "flyover country" today is on the verge of the same kind of boom that took hold in America 100 years ago. You see, Australia is home to nearly all the valuable mineral and metal deposits needed for the industrialization of China and India.
DailyWealth | May 9, 2008
The Past and Future of Energy
DailyWealth | May 12, 2006
Legal Notices: Stansberry Research LLC (Stansberry Research) is a publishing company and the indicators, strategies, reports, articles and all other features of our products are provided for informational and educational purposes only and should not be construed as personalized investment advice. Our recommendations and analysis are based on SEC filings, current events, interviews, corporate press releases, and what we've learned as financial journalists. It may contain errors and you shouldn't make any investment decision based solely on what you read here. It's your money and your responsibility.

 

Readers should be aware that trading stocks and all other financial instruments involves risk. Past performance is no guarantee of future results, and we make no representation that any customer will or is likely to achieve similar results.

 

Our testimonials are the words of real subscribers received in real letters, emails, and other feedback who have not been paid for their testimonials. Testimonials are printed under aliases to protect privacy, and edited for length. Their claims have not been independently verified or audited for accuracy. We do not know how much money was risked, what portion of their total portfolio was allocated, or how long they owned the security. We do not claim that the results experienced by such subscribers are typical and you will likely have different results.

 

Any performance results of our recommendations prepared by Stansberry Research are not based on actual trading of securities but are instead based on a hypothetical trading account. Hypothetical performance results have many inherent limitations. Your actual results may vary.

 

Stansberry Research expressly forbids its writers from having a financial interest in any security they recommend to our subscribers. And all Stansberry Research (and affiliated companies), employees, and agents must wait 24 hours after an initial trade recommendation is published on the Internet, or 72 hours after a direct mail publication is sent, before acting on that recommendation.

 

© 2024 Stansberry Research, LLC. | Privacy Policy| Customer Service
Stansberry Research. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This website may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Stansberry Research, LLC. 1125 N Charles St. Suite 500, Baltimore MD 21202.